FT516 in Subjects With Advanced Hematologic Malignancies
Clinical trial NCT04023071 · TERMINATED
Trial details
- NCT number
- NCT04023071
- Sponsor
- Fate Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-04
- Primary completion
- 2023-10-23
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.